These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7388790)

  • 1. Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion.
    Fraile RJ; Baker LH; Buroker TR; Horwitz J; Vaitkevicius VK
    Cancer Res; 1980 Jul; 40(7):2223-8. PubMed ID: 7388790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
    Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and pharmacokinetic studies of prolonged administration of high-dose uridine intended for rescue from 5-FU toxicity.
    van Groeningen CJ; Leyva A; Kraal I; Peters GJ; Pinedo HM
    Cancer Treat Rep; 1986 Jun; 70(6):745-50. PubMed ID: 3731137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of pharmacokinetics of 5-fluorouracil and 5-fluorouracil with concurrent thymidine infusions in a Phase I trial.
    Kirkwood JM; Ensminger W; Rosowsky A; Papathanasopoulos N; Frei E
    Cancer Res; 1980 Jan; 40(1):107-13. PubMed ID: 7349890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steady-state nonlinear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusions in cancer patients.
    Wagner JG; Gyves JW; Stetson PL; Walker-Andrews SC; Wollner IS; Cochran MK; Ensminger WD
    Cancer Res; 1986 Mar; 46(3):1499-506. PubMed ID: 3943107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and pharmacokinetic effects of combined warfarin and 5-flourouracil in advanced colon cancer.
    Chlebowski RT; Gota CH; Chan KK; Weiner JM; Block JB; Bateman JR
    Cancer Res; 1982 Nov; 42(11):4827-30. PubMed ID: 7127318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of 5-fluorouracil in rabbits in experimental regional chemotherapy.
    Kar R; Cohen RA; Terem TM; Nahabedian MY; Wile AG
    Cancer Res; 1986 Sep; 46(9):4491-5. PubMed ID: 3731104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile.
    Heggie GD; Sommadossi JP; Cross DS; Huster WJ; Diasio RB
    Cancer Res; 1987 Apr; 47(8):2203-6. PubMed ID: 3829006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of 5-fluorouracil in plasma by GC/MS using an internal standard. Applications to pharmacokinetics.
    Cano JP; Rigault JP; Aubert C; Carcassonne Y; Seitz JF
    Bull Cancer; 1979; 66(1):67-74. PubMed ID: 420949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil.
    Klubes P; Cerna I
    Cancer Res; 1983 Jul; 43(7):3182-6. PubMed ID: 6850628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intravenous dose and schedule on cerebrospinal fluid pharmacokinetics of 5-fluorouracil in the monkey.
    Kerr IG; Zimm S; Collins JM; O'Neill D; Poplack DG
    Cancer Res; 1984 Nov; 44(11):4929-32. PubMed ID: 6488155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of 5-fluorouracil administered by slow infusion and rapid injection.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Res; 1972 Dec; 32(12):2717-9. PubMed ID: 4566290
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of vindesine given as an intravenous bolus and 24-hour infusion in humans.
    Ohnuma T; Norton L; Andrejczuk A; Holland JF
    Cancer Res; 1985 Jan; 45(1):464-9. PubMed ID: 3965152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP technical report on the toxicity studies of p-tert-butylcatechol (CAS No. 98-29-3) administered in feed to F344/N rats and B6C3F1 mice.
    Dunnick J
    Toxic Rep Ser; 2002 Nov; (70):5-51. PubMed ID: 12592414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM).
    Gebbia V; Caruso M; Borsellino N; Ajello R; Tirrito ML; Chiarenza M; Valenza R; Verderame F; Varvara F; Marrazzo A; Bajardi E; Ferrao F; Bordonaro R; Tralongo P
    Anticancer Res; 2006; 26(4B):3143-50. PubMed ID: 16886648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonlinear pharmacokinetics of thymidine, thymine, and fluorouracil and their kinetic interactions in normal dogs.
    Covey JM; Straw JA
    Cancer Res; 1983 Oct; 43(10):4587-95. PubMed ID: 6883317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of heparin. II. Studies of time dependence in rats.
    Bjornsson TD; Levy G
    J Pharmacol Exp Ther; 1979 Aug; 210(2):243-6. PubMed ID: 458631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxel.
    Britten CD; Baker SD; Denis LJ; Johnson T; Drengler R; Siu LL; Duchin K; Kuhn J; Rowinsky EK
    Clin Cancer Res; 2000 Sep; 6(9):3459-68. PubMed ID: 10999729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutual kinetic interaction between 5-fluorouracil and bromodeoxyuridine or iododeoxyuridine in dogs.
    Smith DE; Brenner DE; Knutsen CA; Deremer SJ; Terrio PA; Johnson NJ; Stetson PL; Ensminger WD
    Drug Metab Dispos; 1993; 21(2):277-83. PubMed ID: 8097697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of administration route in the therapeutic efficacy of doxifluridine.
    Trave F; Canobbio L; Au JL; Rustum YM
    J Natl Cancer Inst; 1987 Mar; 78(3):527-32. PubMed ID: 2950266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.